Viridian Therapeutics Eulerpool Nieuws

Viridian Therapeutics Eulerpool News

Viridian Therapeutics Aandeel Nieuws

Viridian Therapeutics wordt door vele journalisten en beleggers wereldwijd gevolgd. De meest actuele Viridian Therapeutics nieuwsberichten verzamelen we hier.

• 25 juli ·

  Yahoo
  Viridian Therapeutics Announces Completion of THRIVE-2 Enrollment for VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED)
• 25 juli ·

  Thefly.com
  Viridian Therapeutics completes enrollment in THRIVE-2 trial
• 18 juli ·

  TipRanks
  Buy Rating for Viridian Therapeutics on VRDN-001 Clinical Advancements and Market Potential
• 16 juli ·

  Thefly.com
  Wedbush reveals three potential buyout targets for Biogen
• 3 juli ·

  Yahoo
  Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 20 juni ·

  TipRanks
  Viridian Therapeutics’ Shareholders Approve Equity Plan Expansion
• 12 juni ·

  SeekingAlpha
  Viridian Therapeutics: Key Catalysts Coming In The Second Half Of The Year
• 12 juni ·

  TipRanks
  Ladenburg Thalmann & Co. Remains a Hold on Viridian Therapeutics (VRDN)
• 11 juni ·

  TipRanks
  Analysts Offer Insights on Healthcare Companies: Longboard Pharmaceuticals (LBPH) and Viridian Therapeutics (VRDN)
• 11 juni ·

  Yahoo
  Viridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye Disease